FDA guidance
Appeal Options Available to Mammography Facilities Concerning Adverse Accreditation…
FDA guidance · Final · issued Sep 10, 2024
Key facts
| Title | Appeal Options Available to Mammography Facilities Concerning Adverse Accreditation Decisions, Suspension/Revocation of Certificates, or Patient and Referring Provider Notification Orders: Guidance for Mammography Facilities and Food and Drug Administration Staff |
|---|---|
| Status | Final |
| Issue date | Sep 10, 2024 |
| Center | Center for Devices and Radiological Health |
| Issuing office | Center for Devices and Radiological Health |
| Communication type | Guidance Document |
| Regulated product | Medical Devices, Radiation-Emitting Products |
| Topics | Investigation & Enforcement |
| Docket number | FDA-2020-D-1317 |
| Open for comment | No |
| Document on fda.gov | fda.gov |
At a glance
- None Product codes referenced
- None Recognized standards referenced
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA guidance documents
FDA guidance documents describe the agency's current thinking on regulatory topics. Drafts are issued for comment before a final version is published.
Source: U.S. Food and Drug Administration (FDA), Guidance Documents